FDA Inspection 1199067 — Vitalant
The FDA completed an inspection of Vitalant on February 24, 2023 in Reno, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 24, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Reno, NV (United States)